ABOUT MEDNAVIGATE
At MedNavigate LLC, our mission is to empower emerging and mid-size life sciences companies to achieve commercial success by transforming scientific insights into actionable strategies. We specialize in identifying and quantifying unmet patient needs and developing data-driven strategies, tools, and narratives that articulate the true value of new therapies. By working side by side with our clients, we provide scientifically grounded, hands-on support that ensures every step of the journey is guided by evidence, collaboration, and a shared commitment to improving patient outcomes. As an advisor, Nancy brings a unique combination of analytical expertise, industry knowledge, and strategic insight. With advanced training in health economics and outcomes research, she excels at synthesizing complex data and translating it into compelling value stories that resonate with stakeholders across the healthcare landscape.
HEATH ECONOMICS AND MARKET ACCESS
Dr. Hedlund has partnered with organizations of all sizes, ranging from early-stage start-ups to top 50 global life sciences companies. Her team has guided clients through critical projects by providing both strategic insights and analytical support to enable market access. Her professional portfolio includes leadership roles with Astellas, Baxter Healthcare Corporation, Hospira (a Pfizer Company), and AmerisourceBergen, alongside nearly 15 years of clinical experience as a registered pharmacist. Nancy has built and led cross-functional teams, collaborating with medical and marketing leaders to develop evidence-based strategies that improve patient care and enable product adoption.
REGULATORY PATHWAYS AND SPEAKING ENGAGEMENTS
A recognized thought leader, Dr. Hedlund speaks on the use of real-world evidence in drug development and regulatory submissions. She serves as a guest lecturer at Northwestern University and is an active member of several professional organizations, including ISPOR, AMCP, Women in BIO (WIB), and HerCSuite. She is also a credentialed consultant with ProNexusAdvisory and A-Connect.
INVITE DR. HEDLUND TO SPEAK TO YOUR ORGANIZATION
PUBLICATIONS AND PATENTS
Real-World Use of FLT3-TKIs in R/R FLT3-Mutated AML in the United States. Grinblatt DL, Pandya B, Han W, Sullivan L, Feng Q, Hedlund N. Blood. 2020, vol 136. American Society of Hematology conference abstract (Nov. 5, 2020).
Real-world analysis of prostate-specific antigen (PSA) outcomes among patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide (ENZA). Stephen J. Freedland, Neil M. Schultz, Anna D. Coutinho, Rupali Fuldeore, Nancy Hedlund, Qi Feng, Krishnan Ramaswamy, and Agnes Hong. Journal of Clinical Oncology. 2020; 38:6 suppl, 33-33.
Drug shortage impacts patient receipt of induction treatment. NG Hedlund, Z Isgor, J Zwanziger, D Rondelli, SY Crawford, DM Hynes, LM Powell. Health services research. 2018; 53 (6), 5078-5105. https://doi.org/10.1111/1475-6773.1302.
Systematic evidence review of rates and burden of harm of intravenous admixture drug preparation errors in healthcare settings. N Hedlund, I Beer, T Hoppe-Tichy, P Trbovich. BMJ open. 2017; 7 (12), e015912.
Primary intravenous set consumption across 3 branded infusion pumps.N Hedlund, S Sarangpur, S Kayler, K O’Brien, I Beer. Journal of Infusion Nursing. 2017; 40 (4), 206.
Hedlund, NG. (2017) Impact of drug shortages on patient treatment and survival: The case of cytarabine and AML leukemia. [Doctoral dissertation, University of Illinois at Chicago, Chicago, IL]. ProQuest Dissertations Publishing.
A systematic review of trends, rates and burden of harm associated with intravenous drug preparation errors in healthcare settings (PS-058). N Hedlund. European Journal of Hospital Pharmacy. 2015; 22 (Suppl 1), A159-A159.
A systematic evidence review of trends, rates, and burden of harm associated with Intravenous drug preparation errors in healthcare settings (PS-058). N Hedlund. Presented at the European Association of Hospital Pharmacists (EAHP) Congress, Hamburg, Germany; 25–27 March 2015.
Dissemination of patient navigation programs across the United States.N Hedlund, BC Risendal, H Pauls, PA Valverde, E Whitley, A Esparza, E Calhoun. Journal of Public Health Management and Practice. 2014; 20 (4), E15-E24.
Evaluating the cost-effectiveness of using boceprevir and telaprevir in the treatment of newly diagnosed Hepatitis C genotype 1 patients: A payer’s perspective. YJ Jalundhwala, P Patel, N Hedlund, W Cheng, B Manzoor, H Patel, D Touchette. Pharmacotherapy. 2012; 32 (10), E300-E301.
The importance of staff diversity to address disparity. Nancy Hedlund, Angelina Esparza, Jerome Yates. Physician executive. 2012; 38 (5), 6
Proceedings of a summit on preventing patient harm and death from iv medication errors Bona Benjamin, Peter B Angood, Frederick Blum, Carolyn M Clancy, Diane D Cousins, Gerald J Dal Pan, Cindy Dusik, Frank Federico, Mary Ann Gibbons, Paul A Gluck, Karl F Gumpper, Lisa Hines, Patricia L Holbrook, Beverly J Holcombe, Henri R Manasse, Donald E Martin, Denise Maxwell-Downing, Virginia R McCann, Kathleen M McCauley, Janet M Nagamine, Richard B Osteen, Jack M Percelay, Jeffrey M Rothschild, Matt Scanlon, Lisa Schulmeister, Rowena N Schwartz, Scott R Smith, Erin Sparnon, Allen J Vaida, Cora Vizcarra, Mary Alexander, Mary Baker, Magda Barini-García, Debra K Bello, Ginny Blocki, Jeffrey Carlisle, Kevin J Colgan, Jeffrey B Cooper, Charles E Daniels, Cheryl Graziano, Peggi Guenter, Nancy Hedlund, Harry Jablonski, Patricia C Kienle, Nancy J Kramer, Ronda K Lehman, Stephen R Lewis, Michelle M Mandrack, James C McAllister, Robert B Meek, William F Minogue, Brent Nibarger, Jeffrey S Nordquist, Shawn O’Connell, Nelson R Patterson, Kelly L Podgorny, Deb R Saine, Kevin A Scheckelhoff, Janet A Silvester, Nathaniel M Sims, Christine Snyder, May Britt Sten, Marc Stranz, John P Straumanis, Dennis K Tribble, Tim Vanderveen, John Vaneeckhout, Billie Whitehurst. American Journal of Health-system Pharmacy. 2011; 65 (24), 2367-2379.
Patents
Systems and methods for a graphical interface including a graphical representation of medical data. JA Hume, R Mayer, DA Lee, G Christensen, C Arvelo, TL Ruchti, TBan, MM Khair, NG Hedlund. US Patent 10,430,761 [2019].
System and method for comparing and utilizing activity information and configuration information from multiple medical device management systems. SI Butler, TM Dunsirn, DE Frede, NG Hedlund, TF Polonus, SJ Pregulman, TJ Ramaker, JE Tillery, MK Van Huis. US Patent 10,242,060 [2019].
System and method for comparing and utilizing activity information and configuration information from multiple medical device management systems.SI Butler, TM Dunsim, DE Frede, NG Hedlund, TF Polonus, SJ Pregulman, TJ Ramaker, JE Tillery, MK Van Huis.US Patent 8,799,012 [2014].
D-U-N-S: 012084470
Vendor Registration: IPG-0485677
CAGE: 94ME9 | Expiration: August 11, 2022